Emmaus Life Sciences (EMMA) Cash & Current Investments (2010 - 2026)
Emmaus Life Sciences (EMMA) recorded Cash & Current Investments of $2.81 million in Q2 2026, up 216.9% from $886,000 a year earlier and up 161.9% from the prior quarter.
Emmaus Life Sciences (EMMA) Cash & Current Investments (2010 - 2026) Analysis & Trends
At the end of FY2025, Emmaus Life Sciences reported Cash & Current Investments of $2.13 million, up 53.1% from FY2024.
- Annual Cash & Current Investments has a five-year compound annual growth rate of -3.1% (FY2020 to FY2025).
- Across earlier years, Cash & Current Investments came in at $1.39 million in FY2024 (-45.5%), $2.55 million in FY2023 (+26.0%), $2.02 million in FY2022 (-11.3%) and $2.28 million in FY2021 (-8.4%).
- The Q2 2026 figure is the highest quarterly Cash & Current Investments since Q1 2021.
- On a year-over-year basis, Cash & Current Investments rose in two of the last eight quarters, with growth averaging 6.0%.
- Peak year-over-year performance for Cash & Current Investments in the last five years was growth of 216.9% in Q2 2026, against a decline of 78.4% in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.07 million (Q1 2026), $2.13 million (Q4 2025) and $293,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 2.81 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.81 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 2.13 Mn |
| Sep 30, 2025 | 293,000.00 |
| Jun 30, 2025 | 886,000.00 |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1.26 Mn |
| Jun 30, 2024 | 1.53 Mn |
| Mar 31, 2024 | 1.71 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.77 Mn |
| Dec 31, 2022 | 2.02 Mn |
| Sep 30, 2022 | 1.18 Mn |
| Jun 30, 2022 | 982,000.00 |
| Mar 31, 2022 | 813,000.00 |
| Dec 31, 2021 | 2.28 Mn |
| Sep 30, 2021 | 2.32 Mn |
Emmaus Life Sciences Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EMMA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();